Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 escherichia coli strains

Kwang Sik Kim, Alan S. Cross, Bennett Kaufmann, Wendell Zollinger, Jerald Sadoff

Research output: Contribution to journalArticlepeer-review

Abstract

Murine hybridoma antibodies directed against the capsule and O-side chain determinants of the Escherichia coli strain Bort (018ac:K1:H7) were evaluated for their ability to enhance bactericidal activity of cord blood against K1 E. coli strains possessing O antigens common in neonatal E. coli infection, i.e. 018, 07, and 01. The antibodies to the Kl capsule and O-side chain efficiently enhanced cord polymorphonuclear leukocyte-mediated killing of Kl encapsulated E. coli strain possessing a homologous O antigen, but the IgM antibody to the Kl capsule exhibited approximately 10-fold greater activity than did the IgG3 antibody to O-side chain (weight basis). Both antibodies required complement for their opsonic activities. Our findings indicate that antibodies directed against the capsule and O-lipopolysaccharides are able to restore the opsonic activity of cord blood against Kl E. coli, suggesting that these antibodies may be useful in the prevention and therapy of neonatal E. coli infection.

Original languageEnglish (US)
Pages (from-to)667-670
Number of pages4
JournalPediatric research
Volume28
Issue number6
DOIs
StatePublished - Dec 1990

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 escherichia coli strains'. Together they form a unique fingerprint.

Cite this